Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure

Molecular and Cellular Biochemistry

Volumn 228, Issue 1-2, 2001, Pages 33-37

  Chmielewski, Michal ^a   Nieweglowski, Tomasz ^a   Swierczynski, Julian ^a   Rutkowski, Boleslaw ^a   Boguslawski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cholesterol biosynthesis; Chronic renal failure; HMG CoA reductase; Hypercholesterolemia; Mevalonate

Indexed keywords

ACETIC ACID; CARBON 14; CHOLESTEROL; CREATININE; LIPID; MEVALONIC ACID; PUROMYCIN; STEROL; TRITIUM OXIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; EXPERIMENTAL MODEL; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; INTESTINE EPITHELIUM; LIPID METABOLISM; LIVER SLICE; MALE; NEPHROTIC SYNDROME; NONHUMAN; RAT; RISK FACTOR; VASCULAR DISEASE;

ANIMALS; BODY WEIGHT; CHOLESTEROL; CIRCADIAN RHYTHM; CREATININE; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; INTESTINES; KIDNEY FAILURE, CHRONIC; LIVER; MALE; MEVALONIC ACID; RATS; RATS, WISTAR; UREA;

ANIMALIA;

EID: 0035704694     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013395921241     Document Type: Article

References (19)

1. Evaluation of serum lipid abnormalities in chronic nephritis
2. Genesis of atherosclerosis in uremic patients
3. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease
4. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure
5. Lovastatin but not Enalapril reduces glomerular injury in Dahl salt-sensitive rats
6. Decreased albuminuria by pravastatin in hyperlipidemic diabetics
7. Partial remission of nephrotic syndrome in patients on long-term simvastatin
8. Rate of lipogenesis and cholesterologenesis in vivo during experimental chronic renal failure in rats
9. Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol 7-alpha-hydroxylaze in chronic renal failure
10. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7-alpha-hydroxylaze in rast with subtotal nephrectomy
11. Modulation of the enzymic activity of 3-hydroxy-3-methylglutharyl coenzyme A reductase by multiple kinase system involving reversible phosphorylation
12. The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein
13. Studies on alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats
14. The mevalonate pathway and renal diseases: Experimental and clinical implications
15. Low leptin mRNA level in adipose tissue and normoleptinemia in experimental chronic renal failure
16. A revision of the Schoenheimer-Sperry method for cholesterol determination
17. Downregulation of atrial natriuretic factor clearance receptors in experimental chronic renal failure rats
18. Downregulation of VLDL receptor expression in experimental chronic renal failure
19. Plasma mevalonate in uremic patients